For adults with T2DM, statin initiation is associated with reductions in all-cause mortality and major CVD risk.

The U.S. Centers for Disease Control and Prevention has reduced the number of diseases protected by routine childhood vaccines from 17 to 11. HealthDay News — Federal health officials have decided to ...

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk ...

Among persons with a first positive lung cancer screening result at age 65 years or older, the rate of guideline-concordant ...

Review clinical classifications, diagnostic procedures, and management strategies for cardiomyopathy and heart failure in this comprehensive overview.

Researchers assessed the risk for serious infection during pregnancy and postpartum based on TNF inhibitor exposure among women with chronic inflammatory disease.

For Black breast cancer survivors, higher consumption of ultra-processed foods (UPFs) seems to adversely affect breast cancer prognosis.

The American Heart Association has published a scientific statement on the effect of mitochondrial genetics on cardiovascular health.

Financial strain and food insecurity are found to be the strongest social drivers of accelerated biological heart aging.

The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.

The FDA has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).

The FDA approved a new safety warning for Depo-Provera alerting patients to a possible risk for a type of brain tumor called meningioma.